News
Artificial intelligence chatbots could help with the introduction of a twice-yearly shot that can help prevent HIV, experts ...
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...
French health officials received dozens of reports of syringe pricks at a public festival, sparking fear about HIV and ...
As HIV cases continue to rise in the Philippines, especially among the youth, a new global development may offer hope in ...
A breakthrough HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and ...
HIV pharma leaders are at Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...
GENEVA, (CMC)-The World Health Organization (WHO) on Monday advised countries, including those in the Caribbean to ensure ...
LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...
In recent months, reports of rising HIV infections in Malaysia have once again made national headlines. The data paints a ...
Aurobindo Pharma will manufacture and supply these injectable HIV treatment across 133 countries, including several low and ...
As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...
ViiV's Cabenuva is administered every two months and was offered to HIV patients who achieved viral suppression from daily treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results